Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Pembrolizumab Therapy Exacerbates EBV-Induced Infections and Tumors in a Long-Term Fully Humanized Mouse Model

Renata Stripecke, Prof., Simon Danisch, PhD, Constanze Slabik, Reinhard Zeidler, Prof., Wolfgang Hammerschmidt, Prof., Friedrich Feuerhake, Arnold Ganser, MD

Blood (2018) 132 (Supplement 1): 2405.

https://doi.org/10.1182/blood-2018-99-111693

Published: 2018

Journal Articles

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Blood (2016) 127 (7): 869–881.

https://doi.org/10.1182/blood-2015-10-673236

Published: 2016

Includes: Supplemental data

Journal Articles

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Blood (2014) 124 (21): 74.

https://doi.org/10.1182/blood.V124.21.74.74

Published: 2014

Journal Articles

High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Primary CNS Lymphoma: Updated Results from a Pilot and Phase II Study

Gerald Illerhaus, Fabian Müller, Friedrich Feuerhake, J.ürgen Finke

Blood (2008) 112 (11): 3594.

https://doi.org/10.1182/blood.V112.11.3594.3594

Published: 2008

Journal Articles

Age-Stratified Treatment-Modalities for Patients with Primary CNS Lymphoma: Results of a Phase II Study and Two Pilot-Studies.

Gerald Illerhaus, MD, Reinhard Marks, MD, Fabian Mueller, Friedrich Feuerhake, MD, Christoph Ostertag, MD, Jurgen Finke, MD

Blood (2006) 108 (11): 4683.

https://doi.org/10.1182/blood.V108.11.4683.4683

Published: 2006

Journal Articles

Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma

Hidenobu Takahashi, Friedrich Feuerhake, Stefano Monti, Jeffery L. Kutok, Jon C. Aster, Margaret A. Shipp

Blood (2006) 107 (2): 844–845.

https://doi.org/10.1182/blood-2005-07-2827

Published: 2006

Journal Articles

FAS Death Domain Deletions and Increased c-FLIPlong Expression Occur in Different Subtypes of Diffuse Large B-Cell Lymphoma.

Hidenobu Takahashi, MD, PhD, Friedrich Feuerhake, MD, Jeffery L. Kutok, MD, PhD, Stefano Monti, PhD, Paola S. Dal Cin, PhD, Donna Neuberg, Sc.D, Jon C. Aster, MD, PhD, Margaret A. Shipp, MD

Blood (2005) 106 (11): 416.

https://doi.org/10.1182/blood.V106.11.416.416

Published: 2005

Journal Articles

Signatures of Response to the Proteasome Inhibitor Bortezomib in Diffuse Large B-Cell Lymphoma.

Friedrich Feuerhake, MD, Stefano Monti, PhD, Jonathan Blank, PhD, Erxi Wu, MD, Wen Chen, MD, Todd R. Golub, MD, PhD, Margaret A. Shipp, MD

Blood (2005) 106 (11): 608.

https://doi.org/10.1182/blood.V106.11.608.608

Published: 2005

Journal Articles

NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

Friedrich Feuerhake, Jeffery L. Kutok, Stefano Monti, Wen Chen, Ann S. LaCasce, Giorgio Cattoretti, Paul Kurtin, Geraldine S. Pinkus, Laurence de Leval, Nancy L. Harris, Kerry J. Savage, Donna Neuberg, Thomas M. Habermann, Riccardo Dalla-Favera, Todd R. Golub, Jon C. Aster, Margaret A. Shipp

Blood (2005) 106 (4): 1392–1399.

https://doi.org/10.1182/blood-2004-12-4901

Published: 2005

Includes: Supplemental data

Journal Articles

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Blood (2005) 105 (5): 1851–1861.

https://doi.org/10.1182/blood-2004-07-2947

Published: 2005

Includes: Supplemental data

Journal Articles

Molecular Profiling of Diffuse Large B-Cell Lymphoma Identifies Robust Subtypes Including One Characterized by Host Inflammatory Response.

Blood (2004) 104 (11): 25.

https://doi.org/10.1182/blood.V104.11.25.25

Published: 2004

Journal Articles

NFκB Activation in Primary Mediastinal Large B-Cell Lymphoma: Nuclear Localization of c-REL and Coordinate Upregulation of NFκB Target Genes.

Friedrich Feuerhake, MD, Jeffery L. Kutok, MD, PhD, Stefano Monti, PhD, Giorgio Cattoretti, MD, Paul Kurtin, MD, Geraldine S. Pinkus, MD, Laurence de Leval, MD, Nancy L. Harris, MD, Kerry J. Savage, MD, Thomas M. Habermann, MD, Riccardo Dalla-Favera, MD, Todd R. Golub, MD, Jon C. Aster, MD, PhD, Margaret A. Shipp, MD, PhD

Blood (2004) 104 (11): 243.

https://doi.org/10.1182/blood.V104.11.243.243

Published: 2004

Journal Articles

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

Blood (2003) 102 (12): 3871–3879.

https://doi.org/10.1182/blood-2003-06-1841

Published: 2003

Includes: Supplemental data

NARROW

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Pembrolizumab Therapy Exacerbates EBV-Induced Infections and Tumors in a Long-Term Fully Humanized Mouse Model

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

High-Dose Chemotherapy and Autologous Stem-Cell Transplantation for Primary CNS Lymphoma: Updated Results from a Pilot and Phase II Study

Age-Stratified Treatment-Modalities for Patients with Primary CNS Lymphoma: Results of a Phase II Study and Two Pilot-Studies.

Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma

FAS Death Domain Deletions and Increased c-FLIPlong Expression Occur in Different Subtypes of Diffuse Large B-Cell Lymphoma.

Signatures of Response to the Proteasome Inhibitor Bortezomib in Diffuse Large B-Cell Lymphoma.

NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

Molecular Profiling of Diffuse Large B-Cell Lymphoma Identifies Robust Subtypes Including One Characterized by Host Inflammatory Response.

NFκB Activation in Primary Mediastinal Large B-Cell Lymphoma: Nuclear Localization of c-REL and Coordinate Upregulation of NFκB Target Genes.

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only